Navigation Links
America's Pharmaceutical Research Companies Donate $25 Million to Relief Efforts in Haiti; More Help Coming
Date:1/29/2010

WASHINGTON, Jan. 29 /PRNewswire-USNewswire/ -- As the need for health care assistance mounts after the recent catastrophic earthquake in Haiti, America's pharmaceutical research and biotechnology companies continue to provide help.  So far, more than $25 million in medicines, medical supplies and cash have been committed to relief efforts – and that amount is still growing.  The total does not include the contributions of PhRMA member company employees and the many companies committed to matching the pledges of their workers.

PhRMA companies making donations include: Abbott, Amgen Inc., Astellas Pharma US, Inc., AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Daiichi Sankyo, Inc., Eisai Inc., Endo Pharmaceuticals, Inc., GlaxoSmithKline, Inspire Pharmaceuticals, Inc., Johnson & Johnson, Eli Lilly and Company, Lundbeck Inc., Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Otsuka America, Inc., Pfizer Inc, Purdue Pharma L.P., sanofi-aventis U.S., Takeda Pharmaceuticals North America, Inc. and Talecris.

PhRMA President and CEO Billy Tauzin said: "The day the news broke about the tragedy in Haiti, America's biopharmaceutical companies got to work – coordinating efforts with relief organizations and health care groups already on the ground – making sure everything from simple antibiotic creams to critical medicines were made accessible to victims. And the more the need for medicinal aid is defined, the more our companies are providing it."

Some of the medical and disaster relief organizations that PhRMA companies are coordinating with in Haiti include the World Health Organization, UNICEF and the Red Cross (via various national associations), as well as Americares, Catholic Medical Mission Board, Direct Relief International, MAP International, Partners in Health, Project HOPE, Save the Children and World Vision.

PhRMA is also involved in the Haitian effort through the Rx Response program.  This program, which was developed following Hurricane Katrina, has shed light on the most effective methods to donate medical products and the most efficient ways medical professionals can volunteer for the Haiti response effort.

"The vital role of PhRMA companies and their employees in the global community is clearly defined by such catastrophic situations.  It's our civic responsibility to provide health care professionals the tools they need to help save lives, and we're proud to take part in this effort, which will lead to the eventual recovery of Haiti," Tauzin said.

The Pharmaceutical Research and Manufacturers of America  (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.

PhRMA Internet Address: http://www.phrma.org

For information on stories of hope and survival, visit: http://sharingmiracles.com/

For information on how innovative medicines save lives, visit: http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org

For more information on public health emergencies, visit http://www.rxresponse.org

For information on the danger of imported drugs, visit: http://www.buysafedrugs.info

SOURCE Pharmaceutical Research and Manufacturers of America

RELATED LINKS
http://www.phrma.org/

'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Accuray Announces Regionalized Management Strategy for Americas
2. Pres. Clinton Announces Commitment From Inter-American Development Bank, Global Network for Neglected Tropical Diseases, and Pan American Health Organization to Mobilize $30 Million to Fight NTDs in the Americas at CGI Conference
3. Diffusion Pharmaceuticals LLC Closes on $5.9 Million Financing
4. New Research from Best Practices Can Save Biopharma Companies Millions: Pharmaceutical New Product Planning - Structure and Activities to Drive Profitability
5. Ophthalmic Pharmaceutical Drugs - A Global Market Perspective
6. Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV)
7. Intercept Pharmaceuticals Raises $25 Million Series B Financing
8. Poniard Pharmaceuticals Announces Phase 2 Trial of Picoplatin in Metastatic Colorectal Cancer Meets Primary Endpoint and Study Objectives
9. Amylin Pharmaceuticals to Webcast Year-End Financial Results
10. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
11. New White Paper Examines Advanced Mycoplasma Tests - How Real-Time PCR Analysis Helps Save Time and Money for Biopharmaceutical Manufacturers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... -- According to a new market research ... by Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), by Application (Drug ... Hospitals/ Clinics) - Forecast to 2021", published by MarketsandMarkets, ... the forecast period of 2016 to 2021. This market ... from USD 117.3 Million in 2016, at a CAGR ...
(Date:5/25/2016)... IRVINE, Calif. , May 25, 2016 /PRNewswire/ ... of testing for their new reference materials that ... workflows from sample collection to analyses. The rapid ... the demand for researchers to have standard methods ... data being generated. Biases inherently exist at every ...
(Date:5/25/2016)... Florida , May 25, 2016 ... Conference & Expo earlier this month, the numbers and ... revenues continue to climb into the billions, more research ... newly released 4th Edition State of Legal Marijuana Markets ... a cannabis-focused data-analysis firm, much of the increase in ...
Breaking Medicine Technology:
(Date:5/30/2016)... ... May 30, 2016 , ... Shaolin ... warrior 8-day-8 and 8-night special intensive summer training camp starts on June 17th ... camp offers families and children a fun and unique experience with an opportunity ...
(Date:5/28/2016)... ... May 28, 2016 , ... SuperCloset is proud to officially launch our ... day issues, struggles and obstacles veterans’ need to overcome in order to face their ... or retired military veteran(s) with a donated SuperCloset product based on the needs and ...
(Date:5/27/2016)... Angeles, CA (PRWEB) , ... May 27, 2016 , ... ... of Health, so it is not surprising that bariatric surgery has received increased attention ... Business Journal explains. Of course, when it comes to weight loss, most people are ...
(Date:5/27/2016)... ... 2016 , ... With over 60 percent of acute stroke survivors being left ... to aid in the rehabilitation process has steadily increased. Ekso Bionics had been working ... due to stroke. , Ekso Bionics has now received clearance from the U.S. Food ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... bolstered by inspiring human interest stories, courtesy of leaders in the nursing and ... within the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , ...
Breaking Medicine News(10 mins):